In reviewing the historical data on healthcare expenditure on laboratory services in Belgium, there has been a significant upward trend, particularly over the last few years. From 2013 to 2019, year-on-year variations fluctuated modestly, with a general slow growth trend. However, starting in 2020, the expenditures surged dramatically, reflecting a heightened focus on laboratory services, likely influenced by the COVID-19 pandemic. This accelerated growth continued through 2021 and 2022 with significant year-on-year increases of 36.18% and 15.96% respectively. In 2023, the expenditure stood at 1930 million Euros, marking a substantial increase of 17.47% from the previous year.
The average compound annual growth rate (CAGR) over the last five years (2018-2023) has been 17.38%, emphasizing the rapid increase in investment and expenditure in this sector. Looking ahead, forecasted data from 2024 to 2028 suggest continued robust growth, with an expected CAGR of 8.58% and a total growth rate of 50.93% over this period.
Future trends to watch for include advancements in diagnostic technologies, increased preventive care measures, and the integration of artificial intelligence in laboratory diagnostics which are expected to contribute to the sustained growth in healthcare expenditure on laboratory services in Belgium. Additionally, regulatory changes and possible shifts in healthcare funding could also impact future expenditure trends.
